⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer

Official Title: Phase II Study of BAY 43-9006 in Patients With Metastatic Thyroid Cancer

Study ID: NCT00654238

Interventions

sorafenib

Study Description

Brief Summary: The goal of this study is to determine the activity of sorafenib in patients with advanced (metastatic or recurrent) thyroid cancer.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

University of Pennsylvania - Abramson Comprehensive Cancer Center, Philadelphia, Pennsylvania, United States

Contact Details

Name: Marcia S Brose, MD PhD

Affiliation: Unviersity of Pennsylvania - Abramson Comprehensive Cancer Center

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: